Data About Zetia Risks Was Not Fully Revealed
36441
New evidence shows that drug makers Merck and Schering-Plough never published several studies that raised questions about a cholesterol drugâs risks to the liver.
737440
An unsurprising response from the FDA.
389777
BITTER PILL: Federal officials say research was flawed in two major studies showing oral contraceptives cut the risk of heart disease and carried no increased risk of breast cancer - results contrary to many previous findings.
298757
The heart benefits of taking so-called statin drugs to reduce cholesterol might be offset by a slightly increased risk of cancer, although the evidence is by no means clear, U.S. scientists said on Tuesday.
349354
All studies so far provide inconsistent results about the potential heart risks of GlaxoSmithKline Plc's diabetes drug Avandia, the head of the Food and Drug Administration told lawmakers on Wednesday.
142813
A major new study out Monday found that a cholesterol-lowering drug pulled from the US market in 2001 had a substantially higher risk of a serious side effect than three top-selling competitors.
111269
A large portion of the United States&#39; milk and lettuce supply may be contaminated with potentially unsafe levels of a toxic chemical used in rocket fuel, according to data released by the Food and Drug Administration on Monday.
761256
The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress...
264611
Growing evidence that deadly clots can form in drug-coated stents does not mean that the risks of using the devices the benefits, according to a panel of experts.
508415
An early analysis from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show whether there was any increase in heart attacks among patients, but several experts said the evidence still suggested the popular diabetes drug raised the risk of heart attack.
552158
It can be incredibly difficult for patients to ferret out studies of experimental drugs that offer hope to threat their disease. There is no comprehensive database of ongoing clinical trials, but specialists offer advice for the search:
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
683086
The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress said Thursday.
33756
Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements after a failed study generated negative publicity.
65911
WASHINGTON - About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency&#39;s monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
365737
The safety of Merck&#39;s (MRK:NYSE - news - research) Vioxx has been questioned again with the posting of an internal Food and Drug Administration study on the agency&#39;s website.